Cure Pharmaceutical Holding Corp. Note Agreements
12 Contracts & Agreements
- Promissory Note, dated July 22, 2022, issued by Buyer for the benefit of CURE Pharmaceutical (Filed With SEC on July 28, 2022)
- Secured Promissory Note (Filed With SEC on November 2, 2020)
- Note Purchase Agreement (Filed With SEC on November 2, 2020)
- Series B Convertible Note (Filed With SEC on November 2, 2020)
- Series A Convertible Note (Filed With SEC on November 2, 2020)
- Secured Promissory Note, dated September 25, 2020, by and between CURE Pharmaceutical Holding Corp. and Ionic Ventures, LLC (Filed With SEC on September 30, 2020)
- Secured Promissory Note (Filed With SEC on July 28, 2020)
- Convertible Promissory Note dated November 12, 2019 (Filed With SEC on November 14, 2019)
- Convertible Demand Note Issued by Cure Pharmaceutical Holding Corp. to Chemistry Holdings, Inc (Filed With SEC on April 1, 2019)
- Form of Securities Purchase Agreement, by and between the Company and the Investors, with the form of Note (Filed With SEC on October 18, 2018)
- Form of Securities Purchase Agreement between CURE Pharmaceutical Holding Corp. and various investors for up to $5,000 in convertible promissory notes, dated March 20, 2018 (Filed With SEC on March 26, 2018)
- Form of 9% Convertible Promissory Note, dated March 20, 2018 (Filed With SEC on March 26, 2018)
